Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Change in Acquisitions & Divestments (2025)

BioAge Labs (BIOA) has disclosed Change in Acquisitions & Divestments for 1 consecutive years, with $26.0 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments changed N/A to $26.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $51.8 million through Dec 2025, changed N/A year-over-year, with the annual reading at $60.2 million for FY2025, N/A changed from the prior year.
  • Change in Acquisitions & Divestments hit $26.0 million in Q4 2025 for BioAge Labs, up from $25.8 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $26.0 million in Q4 2025 to a low of $25.8 million in Q3 2025.